- Home
- RRBI vs ENGN Comparison
RRBI vs ENGN Comparison
Compare RRBI & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRBI
- ENGN
- Stock Information
- Founded
- RRBI 1998
- ENGN 1999
- Country
- RRBI United States
- ENGN Canada
- Employees
- RRBI N/A
- ENGN N/A
- Industry
- RRBI Hotels/Resorts
- ENGN
- Sector
- RRBI Consumer Discretionary
- ENGN
- Exchange
- RRBI Nasdaq
- ENGN Nasdaq
- Market Cap
- RRBI 406.6M
- ENGN 349.1M
- IPO Year
- RRBI 2019
- ENGN N/A
- Fundamental
- Price
- RRBI $65.00
- ENGN $7.41
- Analyst Decision
- RRBI Buy
- ENGN Buy
- Analyst Count
- RRBI 1
- ENGN 7
- Target Price
- RRBI $67.00
- ENGN $20.29
- AVG Volume (30 Days)
- RRBI 14.3K
- ENGN 265.6K
- Earning Date
- RRBI 10-29-2025
- ENGN 09-11-2025
- Dividend Yield
- RRBI 0.92%
- ENGN N/A
- EPS Growth
- RRBI 23.60
- ENGN N/A
- EPS
- RRBI 5.67
- ENGN N/A
- Revenue
- RRBI $115,623,000.00
- ENGN N/A
- Revenue This Year
- RRBI $6.88
- ENGN N/A
- Revenue Next Year
- RRBI $7.01
- ENGN N/A
- P/E Ratio
- RRBI $11.48
- ENGN N/A
- Revenue Growth
- RRBI 10.19
- ENGN N/A
- 52 Week Low
- RRBI $46.33
- ENGN $2.65
- 52 Week High
- RRBI $68.20
- ENGN $11.00
- Technical
- Relative Strength Index (RSI)
- RRBI N/A
- ENGN 61.08
- Support Level
- RRBI N/A
- ENGN $6.57
- Resistance Level
- RRBI N/A
- ENGN $7.81
- Average True Range (ATR)
- RRBI 0.00
- ENGN 0.60
- MACD
- RRBI 0.00
- ENGN -0.03
- Stochastic Oscillator
- RRBI 0.00
- ENGN 50.88
About RRBI Red River Bancshares Inc.
Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.